S3-Guideline “Exocrine Pancreatic Carcinoma” 20071 ... - DGVS
S3-Guideline “Exocrine Pancreatic Carcinoma” 20071 ... - DGVS
S3-Guideline “Exocrine Pancreatic Carcinoma” 20071 ... - DGVS
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
474<br />
Leitlinie<br />
Table 10 (Fortsetzung)<br />
search level 2 search level 3 search level 4 search level 5<br />
biopsy pathological finding |<br />
content | criteria |<br />
histological report<br />
pathological report<br />
pancreatectomy<br />
preoperative<br />
ultrasound | computer<br />
diagnostic |<br />
tomography | ct | mri |<br />
staging |<br />
bone scan | chest x-ray |<br />
topic 3<br />
response to chemotherapy<br />
endoscopic ultrasound |<br />
ercp | mrcp | pet |<br />
micrometastases |<br />
laparoscopy |<br />
surgical treatment of pancreatic carcinoma (curative intention)<br />
surgery inoperable | nonresectable age | elderly |<br />
Celiac artery |<br />
comorbidity |<br />
truncus coeliacus |<br />
infiltration<br />
Superior mesenteric artery |<br />
Superior mesenteric vein |<br />
Liver/hepatic vein<br />
cholestasis<br />
resection margins<br />
preoperative stent |<br />
ERCP<br />
inoperative ultrasonography |<br />
peritoneal lavage<br />
cytologic examination<br />
perioperative antibiotics |<br />
somastatin |<br />
octreotide<br />
stent<br />
tumor of the head | pylorus preserving<br />
| tumor of the tail | tumor<br />
ofthebody|locallyadvanced<br />
growth | extended lymphadenectomy<br />
| cystic tumors of the<br />
pancreas | intracuctal papillary<br />
mucinous tumor | metastatic |<br />
metastases | laparoscopic | frozen<br />
section | rapid section |<br />
R0 resection<br />
pancreatic fistula<br />
topic 4<br />
adjuvant and neoadjuvant non-surgical therapy of pancreatic carcinoma<br />
adjuvant<br />
chemotherapy<br />
adjuvant chemoradiation | chemoradiotherapy<br />
| radiochemotherapy<br />
radiotherapy |<br />
radiation<br />
chemoradiation |<br />
chemoradiotherapy | radiochemotherapy<br />
histology | pathology |criteria<br />
inflammation | neoplastic<br />
curative resection | R0 resection differentiation | locally<br />
advanced |mircometastases<br />
Age | elderly | ECOG | 5-FU/folinic<br />
acid (Mayo) | 5-FU/folinic acid<br />
(AIO) | Gemcitabine | CapecetabineRegional|Start|timeaftersurgery<br />
| postoperative begin | R 1<br />
resection<br />
R0 resection | UICC |<br />
risk factors<br />
5-fluorouracil continuous infusion<br />
| 5-fluorouracil | Mitomycin |<br />
Gemcitabine | age | elderly |<br />
ECOG | R 1 resection<br />
curative intention<br />
curative intention<br />
chemotherapy curative intention<br />
neoadjuvant<br />
radiotherapy |<br />
neoadjuvant<br />
radiation<br />
locally advanced | inoperable | T 4<br />
| protocol | duration | dosis |<br />
technique | chemotherapy<br />
Adler G et al. <strong>S3</strong>-<strong>Guideline</strong> <strong>“Exocrine</strong> <strong>Pancreatic</strong>… Z Gastroenterol 2008; 46: 449–482<br />
differentiation |<br />
locally advanced |<br />
micrometastases<br />
Downloaded by: Thieme Verlagsgruppe. Copyrighted material.
Change language